SCGN and type 2 diabetes mellitus: Next, a quantitative analysis of the secretagogin staining intensity in insulin and glucagon-positive cells was performed in pancreatic tissue sections from T2D (n = 8) and non-diabetic controls (n = 8) (Table 2).